Thrive Pets LLC – Trademark Portfolio

Entity Type: 16

Thrive Pets LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include SENSOVET, YAKTASTIC, and ALWAYSPUPS. The owner is based in JERSEY CITY, NJ.

3495 JOHN F KENNEDY BLVD PMB #135

JERSEY CITY, NJ 07307

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Thrive Pets LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

31
Natural Agricultural Products (1 filing)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Frequently Asked Questions

How many trademarks does Thrive Pets LLC have?

Thrive Pets LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Thrive Pets LLC file in?

Thrive Pets LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Thrive Pets LLC's most well-known trademarks?

Thrive Pets LLC's registered trademark portfolio includes well-known marks such as SENSOVET, YAKTASTIC, and ALWAYSPUPS. These are among 3 currently registered trademarks in the portfolio.

What is Thrive Pets LLC's trademark registration success rate?

Thrive Pets LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.